The dopamine D-2 antagonist, Ro 22-1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile (IDPN) in mice

This publication has 16 references indexed in Scilit:

• Decreased striatal opiate δ-receptors in the rat model of persistent dyskinesia induced by iminodipropionitrile
  Neuroscience Letters, 1986
• The Citalopram/5‐HTP‐induced Head Shake Syndrome is Correlated to 5‐HT₂ Receptor Affinity and also Influenced by other Transmitters
  Acta Pharmacologica et Toxicologica, 1984
• Treatment of Tourette's Syndrome with RO22–1319, a D-2-Receptor Antagonist
  New England Journal of Medicine, 1984
• Role of the basal ganglia in a chemically induced dyskinesia in rat
  Experimental Neurology, 1984
• Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice
  Neuropharmacology, 1984
• Dopamine receptor model and its application in the design of a new class of rigid pyrrolo[2,3-g]isoquinoline antipsychotics
  Journal of Medicinal Chemistry, 1981
• The effect of the neurolathyrogenic substance β,β′-iminodipropionitrile (IDPN) on some biological parameters in rats and mice
  General Pharmacology: The Vascular System, 1981
• Slow Axonal Transport of Neurofilament Proteins: Impairment of β,β′-Iminodipropionitrile Administration
  Science, 1978
• An animal behavior model for studying central serotonergic synapses
  Life Sciences, 1976
• Regional neurochemical studies on the effect of β,β′ ‐iminodipropionitrile (IDPN) in the rat
  Journal of Neuroscience Research, 1975